134 related articles for article (PubMed ID: 29963821)
21. Immunogenicity difference between two hepatitis E vaccines derived from genotype 1 and 4.
Wen J; Behloul N; Dai X; Dong C; Liang J; Zhang M; Shi C; Meng J
Antiviral Res; 2016 Apr; 128():36-42. PubMed ID: 26850829
[TBL] [Abstract][Full Text] [Related]
22. Construction of a recombinant baculovirus expressing swine hepatitis E Virus ORF2 and preliminary research on its immune effect.
Yang Z; Hu Y; Yuan P; Yang Y; Wang K; Xie LY; Huang SL; Liu J; Ran L; Song ZH
Pol J Vet Sci; 2018 Mar; 21(1):47-54. PubMed ID: 29624021
[TBL] [Abstract][Full Text] [Related]
23. Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®).
Zhang X; Wei M; Pan H; Lin Z; Wang K; Weng Z; Zhu Y; Xin L; Zhang J; Li S; Xia N; Zhao Q
Vaccine; 2014 Jul; 32(32):4039-50. PubMed ID: 24892250
[TBL] [Abstract][Full Text] [Related]
24. Expression of a truncated hepatitis E virus capsid protein in the protozoan organism Leishmania tarentolae and its application in a serological assay.
Baechlein C; Meemken D; Pezzoni G; Engemann C; Grummer B
J Virol Methods; 2013 Oct; 193(1):238-43. PubMed ID: 23747546
[TBL] [Abstract][Full Text] [Related]
25. Investigation of a special neutralizing epitope of HEV E2s.
You M; Xin L; Yang Y; Zhang X; Chen Y; Yu H; Li S; Zhang J; An Z; Luo W; Xia N
Protein Cell; 2014 Dec; 5(12):950-3. PubMed ID: 25416205
[No Abstract] [Full Text] [Related]
26. Immunogenicity and Antigenicity of Rabbit Hepatitis E Virus-Like Particles Produced by Recombinant Baculoviruses.
Bai H; Kataoka M; Ami Y; Suzaki Y; Takeda N; Muramatsu M; Li TC
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452436
[TBL] [Abstract][Full Text] [Related]
27. [Expression, purification and immunogenicity of a novel hepatitis E virus-like particle].
Dong C; Meng JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):339-42. PubMed ID: 16643795
[TBL] [Abstract][Full Text] [Related]
28. Production of capsid proteins of rat hepatitis E virus in Escherichia coli and characterization of self-assembled virus-like particles.
Kobayashi T; Takahashi M; Ohta S; Nagashima S; Primadharsini PP; Mulyanto ; Kunita S; Murata K; Okamoto H
Virus Res; 2021 Sep; 302():198483. PubMed ID: 34146611
[TBL] [Abstract][Full Text] [Related]
29. Characterization of self-assembled virus-like particles of rat hepatitis E virus generated by recombinant baculoviruses.
Li TC; Yoshimatsu K; Yasuda SP; Arikawa J; Koma T; Kataoka M; Ami Y; Suzaki Y; Mai LTQ; Hoa NT; Yamashiro T; Hasebe F; Takeda N; Wakita T
J Gen Virol; 2011 Dec; 92(Pt 12):2830-2837. PubMed ID: 21865442
[TBL] [Abstract][Full Text] [Related]
30. Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies.
Riddell MA; Li F; Anderson DA
J Virol; 2000 Sep; 74(17):8011-7. PubMed ID: 10933710
[TBL] [Abstract][Full Text] [Related]
31. Real-time stability of a hepatitis E vaccine (Hecolin®) demonstrated with potency assays and multifaceted physicochemical methods.
Zhang X; Wei M; Sun G; Wang X; Li M; Lin Z; Li Z; Li Y; Fang M; Zhang J; Li S; Xia N; Zhao Q
Vaccine; 2016 Nov; 34(48):5871-5877. PubMed ID: 27793484
[TBL] [Abstract][Full Text] [Related]
32. Recombinant Hepatitis E virus like particles can function as RNA nanocarriers.
Panda SK; Kapur N; Paliwal D; Durgapal H
J Nanobiotechnology; 2015 Jun; 13():44. PubMed ID: 26104584
[TBL] [Abstract][Full Text] [Related]
33. Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells.
Zhang Y; McAtee P; Yarbough PO; Tam AW; Fuerst T
Clin Diagn Lab Immunol; 1997 Jul; 4(4):423-8. PubMed ID: 9220158
[TBL] [Abstract][Full Text] [Related]
34. Production of a Hepatitis E Vaccine Candidate Using the Pichia pastoris Expression System.
Gupta J; Kumar A; Surjit M
Methods Mol Biol; 2022; 2412():117-141. PubMed ID: 34918244
[TBL] [Abstract][Full Text] [Related]
35. Characterization of self-assembled virus-like particles of ferret hepatitis E virus generated by recombinant baculoviruses.
Yang T; Kataoka M; Ami Y; Suzaki Y; Kishida N; Shirakura M; Imai M; Asanuma H; Takeda N; Wakita T; Li TC
J Gen Virol; 2013 Dec; 94(Pt 12):2647-2656. PubMed ID: 24018315
[TBL] [Abstract][Full Text] [Related]
36. Structure of hepatitis E viral particle.
Mori Y; Matsuura Y
Virus Res; 2011 Oct; 161(1):59-64. PubMed ID: 21440590
[TBL] [Abstract][Full Text] [Related]
37. Spatial configuration of hepatitis E virus antigenic domain.
Xing L; Wang JC; Li TC; Yasutomi Y; Lara J; Khudyakov Y; Schofield D; Emerson SU; Purcell RH; Takeda N; Miyamura T; Cheng RH
J Virol; 2011 Jan; 85(2):1117-24. PubMed ID: 21068233
[TBL] [Abstract][Full Text] [Related]
38. [Expression of ORF2 protein of HEV genotype IV in Hansenula polymorpha].
Su CX; Gu MR; Zhang P; Jin ZJ; Meng FH; Chen EJ; Yang Z; Liu Y; Wang YC
Sheng Wu Gong Cheng Xue Bao; 2007 Jan; 23(1):73-8. PubMed ID: 17366891
[TBL] [Abstract][Full Text] [Related]
39. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
Baek JO; Seo JW; Kim IH; Kim CH
Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
[TBL] [Abstract][Full Text] [Related]
40. A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice.
Xiang K; Kusov Y; Ying G; Yan W; Shan Y; Jinyuan W; Na Y; Yan Z; Hongjun L; Maosheng S
Viruses; 2017 Sep; 9(9):. PubMed ID: 28914805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
